Compare Becton Dickinson and Co (BDX) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Tyson Foods, Inc. — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while Tyson Foods, Inc. trades at $56.65 (market cap $20.11B). The key difference: Becton Dickinson and Co is far larger — about 2.4× Tyson Foods, Inc.'s market cap, and Tyson Foods, Inc. pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| BDX | TSN | |
|---|---|---|
Market Cap | $48.93B | $20.11B |
Sector | Health | Consumer Staples |
52-Week High | $185.39 | $68.75 |
52-Week Low | $138.62 | $50.72 |
Enterprise Value | $65.03B | $27.37B |
Dividend Yield | 2.34% | 3.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.
The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.
Tyson Foods (TSN) trades at $58.04, down 0.85% on the day, with a bearish technical signal and mixed earnings history. The company reported Q3 2026 EPS of $0.99, beating estimates, but revenue trends are pressured by beef segment losses. Valuation metrics show a P/E of 35.83 and P/S of 0.37, with a consensus analyst price target of $68.50. Recent news highlights debt tender offers and a maintained quarterly dividend of $0.51.
The outlook is cautious due to persistent beef margin challenges, though chicken and prepared foods provide stability. Investment appeal lies in the discounted valuation and dividend yield, but risks include volatile input costs and competitive pressures. Analyst sentiment is divided, with 50% buy ratings but bearish technical indicators suggesting near-term pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
